ArticleFrontiers in medicine2026
Optimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prolonged hospitalization for pyogenic liver abscess (PLA) burdens patients and health systems. We examined whether admission high-density lipoprotein cholesterol (HDL-C) predicts length of stay (LOS) and whether a simple HDL-C-reactive protein (CRP) dual-threshold can flag patients at risk of prolonged stay. Methods: We analyzed a prospective adult PLA cohort at a tertiary center (2018-2023; Results: Lower HDL-C independently associated with longer LOS. A nomogram combining HDL-C, abscess size, and sepsis performed well ( Conclusion: Admission HDL-C, particularly when interpreted together with CRP, may help identify PLA patients at increased risk of prolonged hospitalization at the time of admission. Patients with low HDL-C and high CRP may warrant closer monitoring, earlier evaluation for source control or drainage, and more proactive inpatient planning. Prospective implementation studies are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.